Close

Analyst Ratings for Prelude Therapeutics (PRLD) [Sells]

PRLD Rating Summary

PRLD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PRLD
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $5.25 (+52.6%) * Over Last 12-Mos
Rating Score: 2.9 / 10   Percentile Rank: 24%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/19/2023 Morgan Stanley Jeffrey Hung Downgrade Underweight
(Equalweight)
4.00
(10.00)
4.35
(3.44)
-20.92% Details
11/21/2022 BofA Securities Tazeen Ahmad Downgrade Underperform
(Neutral)
6.00
(8.00)
7.44
(3.44)
-53.76% Details